Cellebrite DI (CLBT) Net Margin (2020 - 2025)

Cellebrite DI's Net Margin history runs 6 years deep, the most recent figure standing at 16.5% for Q4 2025.

• On a quarterly basis, Net Margin fell 117.0% year-over-year to 16.5% in Q4 2025; TTM through Dec 2025 was 16.47%, a 8701.0% increase from a year earlier, with the FY2025 full-year figure at 16.36%, up 8690.0% from the prior year.
• Net Margin improved to 16.5% in Q4 2025 per CLBT's latest filing, from 16.02% in the prior quarter.
• Across five years, Net Margin topped out at 88.86% in Q1 2022 and bottomed at 193.8% in Q3 2024.
• The 5-year median for Net Margin is 12.76% (2021), against an average of 1.34%.
• Across the five-year window, Net Margin sank 20152 bps in 2024 and soared 20982 bps in 2025, its largest moves.
• Year by year, Net Margin stood at 76.38% in 2021, then plunged by 87 bps to 9.56% in 2022, then tumbled by 265 bps to 15.75% in 2023, then soared by 212 bps to 17.67% in 2024, then dropped by 7 bps to 16.5% in 2025.
• Per Business Quant, the three latest CLBT Net Margin figures stand at 16.5% (Q4 2025), 16.02% (Q3 2025), and 17.19% (Q2 2025).